Bessemer Group
PRAX icon

Bessemer Group’s Praxis Precision Medicines PRAX Stock Holding History

Bessemer Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Buy
+140
New +$44.3K ﹤0.01% 1718
2025
Q1 		– Sell
-25
Closed -$1.56K – 2675
2024
Q4 		$2K Hold
25
– – ﹤0.01% 2255
2024
Q3 		$1K Buy
+25
New +$1.35K ﹤0.01% 2506
2022
Q2 		– Sell
-4
Closed -$1K – 1998
2022
Q1 		$1K Hold
4
– – ﹤0.01% 1785
2021
Q4 		$1K Hold
4
– – ﹤0.01% 1820
2021
Q3 		$1K Hold
4
– – ﹤0.01% 1632
2021
Q2 		$1K Hold
4
– – ﹤0.01% 1552
2021
Q1 		$2K Buy
+4
New +$2.84K ﹤0.01% 1460

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bessemer Group's PRAX Position: Q2 2026 in Review

Bessemer Group opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 140 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #1718 among its holdings. This is a return to the name: Bessemer Group previously reported a position in PRAX as recently as Q4 2024.

Bessemer Group first reported a position in PRAX in Q1 2021 and has held it in 8 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Bessemer Group held 140 shares of Praxis Precision Medicines worth $47K as of Q2 2026.
  • Praxis Precision Medicines was a new Bessemer Group position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1718 holding.
  • Bessemer Group first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 8 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.